TELA Bio, Inc. (TELA): Revenue

Annual figures by period end, from SEC filings.

$80.28M
Year ended 2025-12-31
$79.91M
Trailing 12 months to 2026-06-30
+24.7%
3-year compound annual growth
+34.5%
5-year compound annual growth
2017-12-31: $4.25M2018-12-31: $8.27M2019-12-31: $15.45M2020-12-31: $18.21M2021-12-31: $29.46M2022-12-31: $41.42M2023-12-31: $58.45M2024-12-31: $69.30M2025-12-31: $80.28M$80.28M
2017-12-31 Revenue (USD) 2025-12-31
Period endedRevenueChange YoYSource filing
2025-12-31$80.28M+15.8%2026-03-25, From 2025-01-01
2024-12-31$69.30M+18.6%2026-03-25, From 2024-01-01
2023-12-31$58.45M+41.1%2026-03-25, From 2023-01-01
2022-12-31$41.42M+40.6%2025-03-21, From 2022-01-01
2021-12-31$29.46M+61.8%2024-03-22, From 2021-01-01
2020-12-31$18.21M+17.9%2023-03-23, From 2020-01-01
2019-12-31$15.45M+86.7%2022-03-23, From 2019-01-01
2018-12-31$8.27M+94.9%2021-03-25, From 2018-01-01
2017-12-31$4.25Mn/a2020-03-30, From 2017-01-01

Revenue at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedRevenueChange YoY
TELA Bio, Inc. (TELA)2025-12-31$80.28M+15.8%
PRO DEX Inc (PDEX)2026-06-30$77.55M+16.5%
Sight Sciences, Inc. (SGHT)2025-12-31$77.36M-3.1%
Iradimed Corp (IRMD)2025-12-31$83.81M+14.4%
Delcath Systems, Inc. (DCTH)2025-12-31$85.23M+129.1%
AVITA Medical, Inc. (RCEL)2025-12-31$71.61M+11.5%
Pulmonx Corp (LUNG)2025-12-31$90.50M+8.0%
Kestra Medical Technologies, Ltd. (KMTS)2026-04-30$95.13M+59.0%
NeuroPace Inc (NPCE)2025-12-31$99.99M+25.1%

Compare TELA, PDEX, SGHT, IRMD side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗